Concepedia

Chiral Impurity Control

Chiral Impurity Control is a methodological framework within impurity control strategies that specifically enables the identification, quantification, and mitigation of enantiomeric impurities in pharmaceutical substances through stereoselective analytical and process technologies.

12

Publications

391

Citations

67

Authors

22

Institutions

Publications per year

2017–2026

2

Parents

Publications

12

Chiral drugs: The FDA perspective on manufacturing and control

Wilson H. De Camp · Journal of Pharmaceutical and Biomedical Analysis · 1993 · 114 citations

, , +13

Use of vancomycin as chiral selector in capillary electrophoresis. Optimization and quantitation of loxiglumide enantiomers in pharmaceuticals

Salvatore Fanali, Claudia Desiderio · Journal of High Resolution Chromatography · 1996 · 68 citations

, , +16

Controlling the Effect of Chiral Impurities on Viedma Ripening

René R. E. Steendam, Bram Harmsen, Hugo Meekes et al. · Crystal Growth & Design · 2013 · 39 citations

, , +11

Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries: Part 3

Ke Huang, Zachary S. Breitbach, Daniel W. Armstrong · Tetrahedron Asymmetry · 2006 · 31 citations

, , +14

Useful impurities for optical resolution. 4. Attempted amplification of optical activity by crystallization of chiral crystals of photopolymerizing dienes in the presence of their topochemical products

J. Van Mil, Lia Addadi, E. Gati et al. · Journal of the American Chemical Society · 1982 · 28 citations

, , +13

1–5 of 12

Authors

67

  1. DZ
    Dan Zhang

    Sun Yat-sen University, China

    1 publications · 22 citations

    1

    h-index

  2. AR
    Arianna Ribecai

    GlaxoSmithKline (Italy), Italy

    1 publications · 12 citations

    1

    h-index

  3. WH
    Wenkai Hui

    Sichuan Agricultural University, China

    1 publications · 20 citations

    1

    h-index

  4. JP
    Jianbiao Peng

    Henan Normal University, China

    1 publications · 12 citations

    1

    h-index

  5. EG
    E. Gati

    Weizmann Institute of Science, Israel

    1 publications · 28 citations

    1

    h-index

1–5 of 67

Institutions

22

  1. Janssen (Belgium)

    Beerse, Belgium

    1 h-index

    3 publications

    39 citations

  2. China University of Geosciences

    Wuhan, China

    1 h-index

    1 publications

    22 citations

  3. Radiocommunications Agency

    Groningen, Netherlands

    1 h-index

    1 publications

    39 citations

  4. Nanjing Tech University

    Nanjing, China

    1 h-index

    7 publications

    140 citations

  5. Tris Pharma (United States)

    Monmouth Junction, United States

    1 h-index

    2 publications

    24 citations

  6. Chongqing Medical and Pharmaceutical College

    Chongqing, China

    1 h-index

    3 publications

    66 citations

  7. Center for Drug Evaluation and Research

    Silver Spring, United States

    1 h-index

    1 publications

    114 citations

  8. Florida International University

    Miami, United States

    1 h-index

    4 publications

    84 citations

1–8 of 22

Venues

  1. 3

    h-index

  2. Organic Process Research & Development

    2 publications · 23 citations

    2

    h-index

  3. Crystal Growth & Design

    1 publications · 39 citations

    1

    h-index

  4. Tetrahedron Asymmetry

    1 publications · 31 citations

    1

    h-index

  5. Journal of the American Chemical Society

    JACS · 1 publications · 28 citations

    1

    h-index

1–5